BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3604394)

  • 21. Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids.
    Zhao DD; Watarai S; Lee JT; Kouchi S; Ohmori H; Yasuda T
    Acta Med Okayama; 1997 Jun; 51(3):149-54. PubMed ID: 9227794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment.
    Gregoriadis G
    Immunomethods; 1994 Jun; 4(3):210-6. PubMed ID: 7820451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes.
    Senior J; Gregoriadis G
    Biochim Biophys Acta; 1989 May; 1003(1):58-62. PubMed ID: 2713395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Jaafari MR; Sajadi Tabassi SA
    Eur J Pharm Biopharm; 2006 Oct; 64(2):138-45. PubMed ID: 16797952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
    Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
    Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of surface-coupled antigen of liposomes in immunopotentiation.
    Latif NA; Bachhawat BK
    Immunol Lett; 1987 May; 15(1):45-51. PubMed ID: 3610232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.
    Vangala A; Bramwell VW; McNeil S; Christensen D; Agger EM; Perrie Y
    J Control Release; 2007 May; 119(1):102-10. PubMed ID: 17331610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
    Badiee A; Jaafari MR; Khamesipour A; Samiei A; Soroush D; Kheiri MT; Barkhordari F; McMaster WR; Mahboudi F
    Exp Parasitol; 2009 Apr; 121(4):362-9. PubMed ID: 19211022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of protein-encapsulating DRV liposomes after freeze-drying: A study with BSA and t-PA.
    Ntimenou V; Mourtas S; Christodoulakis EV; Tsilimbaris M; Antimisiaris SG
    J Liposome Res; 2006; 16(4):403-16. PubMed ID: 17162581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the efficacy of liposomes in comparison to new and established adjuvants in potentiating the antibody response against hepatitis B virus surface antigen.
    Tan L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):83-7. PubMed ID: 1807265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
    Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
    Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.
    Higaki M; Azechi Y; Takase T; Igarashi R; Nagahara S; Sano A; Fujioka K; Nakagawa N; Aizawa C; Mizushima Y
    Vaccine; 2001 Apr; 19(23-24):3091-6. PubMed ID: 11312003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)-poly(DLAla)--(LLys) with high frequency of site-associated idiotypic determinants.
    Lifshitz R; Gitler C; Mozes E
    Eur J Immunol; 1981 May; 11(5):398-404. PubMed ID: 7262180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes as immunological adjuvants for tetanus vaccine.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
    Bhowmick S; Mazumdar T; Sinha R; Ali N
    J Control Release; 2010 Jan; 141(2):199-207. PubMed ID: 19818373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation.
    Shek PN; Yung BY; Stanacev NZ
    Immunology; 1983 May; 49(1):37-44. PubMed ID: 6341213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of surface charges of liposomes in immunopotentiation.
    Latif N; Bachhawat BK
    Biosci Rep; 1984 Feb; 4(2):99-107. PubMed ID: 6713089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins.
    Nakanishi T; Kunisawa J; Hayashi A; Tsutsumi Y; Kubo K; Nakagawa S; Fujiwara H; Hamaoka T; Mayumi T
    Biochem Biophys Res Commun; 1997 Nov; 240(3):793-7. PubMed ID: 9398647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.